Advertisement
Screener

CYRUSONE INC. Derivative, Gain (Loss) on Derivative, Net

CYRUSONE INC. Derivative, Gain (Loss) on Derivative, Net

CYRUSONE INC. reported Derivative, Gain (Loss) on Derivative, Net of $43.60 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-17.

Discontinued › Income Statement › Other Income

us-gaap:DerivativeGainLossOnDerivativeNet · last filed 2022-02-17

  • CYRUSONE INC. derivative, gain (loss) on derivative, net for the quarter ending 2021-12-31 was $12.40M, a 202.44% increase year-over-year.
  • CYRUSONE INC. derivative, gain (loss) on derivative, net for the quarter ending 2021-09-30 was $14.40M.
  • CYRUSONE INC. derivative, gain (loss) on derivative, net for the quarter ending 2021-06-30 was $1.40M.
  • CYRUSONE INC. derivative, gain (loss) on derivative, net for the quarter ending 2021-03-31 was $15.40M, a 201.96% increase year-over-year.
  • CYRUSONE INC. derivative, gain (loss) on derivative, net for fiscal 2021 was $43.60M.
  • CYRUSONE INC. derivative, gain (loss) on derivative, net for fiscal 2020 was -$27.60M.
  • CYRUSONE INC. derivative, gain (loss) on derivative, net for fiscal 2019 was -$7.50M.
  • CYRUSONE INC. derivative, gain (loss) on derivative, net for fiscal 2018 was $0.00.
Period endDerivative, Gain (Loss) on Derivative, Net 3 monthDerivative, Gain (Loss) on Derivative, Net 6 monthDerivative, Gain (Loss) on Derivative, Net 9 monthDerivative, Gain (Loss) on Derivative, Net 12 month
2021-12-31$12.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17
$26.80M
derived: sum of 2 quarters · filed 2022-02-17
$28.20M
derived: sum of 3 quarters · filed 2022-02-17
$43.60M
10-K · filed 2022-02-17
2021-09-30$14.40M
10-Q · filed 2021-10-28
$15.80M
derived: sum of 2 quarters · filed 2021-10-28
$31.20M
10-Q · filed 2021-10-28
$35.30M
derived: sum of 4 quarters · filed 2022-02-17
2021-06-30$1.40M
10-Q · filed 2021-07-29
$16.80M
10-Q · filed 2021-07-29
$20.90M
derived: sum of 3 quarters · filed 2022-02-17
-$2.00M
derived: sum of 4 quarters · filed 2022-02-17
2021-03-31$15.40M
10-Q · filed 2021-04-29
$19.50M
derived: sum of 2 quarters · filed 2022-02-17
-$3.40M
derived: sum of 3 quarters · filed 2022-02-17
-$17.30M
derived: sum of 4 quarters · filed 2022-02-17
2020-12-31$4.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17
-$18.80M
derived: sum of 2 quarters · filed 2022-02-17
-$32.70M
derived: sum of 3 quarters · filed 2022-02-17
-$27.60M
10-K · filed 2022-02-17
2020-09-30-$22.90M
10-Q · filed 2021-10-28
-$36.80M
derived: sum of 2 quarters · filed 2021-10-28
-$31.70M
10-Q · filed 2021-10-28
-$44.70M
derived: sum of 4 quarters · filed 2022-02-17
2020-06-30-$13.90M
10-Q · filed 2021-07-29
-$8.80M
10-Q · filed 2021-07-29
-$21.80M
derived: sum of 3 quarters · filed 2022-02-17
-$16.30M
derived: sum of 4 quarters · filed 2022-02-17
2020-03-31$5.10M
10-Q · filed 2021-04-29
-$7.90M
derived: sum of 2 quarters · filed 2022-02-17
-$2.40M
derived: sum of 3 quarters · filed 2022-02-17
-$2.40M
derived: sum of 4 quarters · filed 2022-02-17
2019-12-31-$13.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17
-$7.50M
derived: sum of 2 quarters · filed 2022-02-17
-$7.50M
derived: sum of 3 quarters · filed 2022-02-17
-$7.50M
10-K · filed 2022-02-17
2019-09-30$5.50M
10-Q · filed 2020-10-29
$5.50M
derived: sum of 2 quarters · filed 2020-10-29
$5.50M
10-Q · filed 2020-10-29
$5.50M
derived: sum of 4 quarters · filed 2021-02-19
2019-06-30$0.00
10-Q · filed 2020-07-31
$0.00
10-Q · filed 2020-07-31
$0.00
derived: sum of 3 quarters · filed 2021-02-19
$0.00
derived: sum of 4 quarters · filed 2021-02-19
2019-03-31$0.00
10-Q · filed 2020-04-30
$0.00
derived: sum of 2 quarters · filed 2021-02-19
$0.00
derived: sum of 3 quarters · filed 2021-02-19
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19
$0.00
derived: sum of 2 quarters · filed 2021-02-19
$0.00
10-K · filed 2021-02-19
2018-09-30$0.00
10-Q · filed 2019-10-31
$0.00
10-Q · filed 2019-10-31
2017-12-31$0.00
10-K · filed 2020-02-20